FRONTIERS Trademark

Trademark Overview

On Monday, December 16, 2024, a trademark application was filed for FRONTIERS with the United States Patent and Trademark Office. The USPTO has given the FRONTIERS trademark a serial number of 98905743. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, June 6, 2025. This trademark is owned by Phase Capital LLC. The FRONTIERS trademark is filed in the Education & Entertainment Services category with the following description:

Arranging and conducting of business conferences in the field of biotechnology, artificial intelligence, quantum computing, space, technology, healthcare, digital health, therapeutics, healthcare information technology, diagnostics, bioinformatics, medical devices, climate, and drug discovery
frontiers

General Information

Serial Number98905743
Word MarkFRONTIERS
Filing DateMonday, December 16, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateFriday, June 6, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesArranging and conducting of business conferences in the field of biotechnology, artificial intelligence, quantum computing, space, technology, healthcare, digital health, therapeutics, healthcare information technology, diagnostics, bioinformatics, medical devices, climate, and drug discovery

Classification Information

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateMonday, December 16, 2024
Primary Code041
First Use Anywhere DateSaturday, October 12, 2024
First Use In Commerce DateTuesday, October 29, 2024

Trademark Owner History

Party NamePhase Capital LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNashville, TN 37210

Trademark Events

Event DateEvent Description
Monday, December 16, 2024NEW APPLICATION ENTERED
Monday, December 16, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 6, 2025NON-FINAL ACTION WRITTEN
Friday, June 6, 2025NON-FINAL ACTION E-MAILED
Friday, June 6, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 3, 2025ASSIGNED TO EXAMINER

Related Keywords

frontiers healthcare technology diagnostics information therapeutics health bioinformatics medical discovery drug